Cathepsin D immunoreactivity in ovarian cancer: Correlation with prognostic factors

Pathology and Oncology Research

Volumn 4, Issue 2, 1998, Pages 103-107

  Athanassiadou, Pauline ^a,b   Sakellariou, Vasiliki ^a   Petrakakou, Efthalia ^a   Athanassiades, Peter ^a   Zerva, Cherry ^a   Liossi, Anna ^a   Michalas, Stylianos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cathepsin D; Immunocytochemistry; Ovarian carcinoma; Prognostic factors

Indexed keywords

CATHEPSIN D; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; CANCER INVASION; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MENOPAUSE; OVARY CARCINOMA; PROGNOSIS; PROTEIN DEGRADATION; TUMOR VOLUME;

EID: 0031823295     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02904702     Document Type: Article

References (5)

1. Bevilacqua P, Boracchi P, Gasparini G: Prognostic indicators for early-stage breast carcinoma. Part II: Value of cathepsin D expression, detected by immunocytochemistry. A multiparametric study. Int J Oncol 5:559-554, 1994.
2. Briozzo P, Morisset M, Capony F, et al: H. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res 48:3688-3692, 1988.
3. Capony F, Rougeot C, Montcurrier P, et al: Increased secretion, altered processing and glycosylation of pro-Cathepsin D in human mammary cancer cells. Cancer Res 49:3904-3909, 1989.
4. Dean RT: Direct evidence of importance of lysosomes in degradation of intracellular protein. Nature 257:414-416, 1975.
5. Delahunt B, Bethwaite PB, Thornton A, Ribas JL: Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labelling. Cancer 75:2714-2719, 1995.